Cargando…

Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes

Objective: There are no comprehensive studies on survival outcomes and optimal treatment protocols for cervical esophageal cancer (CEC), due to its rare clinical prevalence. Our objective was to determine the relationship between pathological characteristics, treatment protocols, and survival outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Peinan, Zhao, Xueke, Zhou, Fuyou, Song, Xin, Hu, Shoujia, Jin, Yan, Wang, Xianzeng, Han, Xuena, Fan, Zongmin, Wang, Ran, Li, Bei, Han, Wenli, Wang, Panpan, Li, Jilin, Wan, Lixin, Zhang, Liguo, Bao, Qide, Chang, Fubao, Qin, Yanru, Chang, Zhiwei, Ku, Jianwei, Yang, Haijun, Yuan, Ling, Ren, Jingli, Li, Xuemin, Wang, Lidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142830/
https://www.ncbi.nlm.nih.gov/pubmed/32296589
http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0268
_version_ 1783519471741173760
author Chen, Peinan
Zhao, Xueke
Zhou, Fuyou
Song, Xin
Hu, Shoujia
Jin, Yan
Wang, Xianzeng
Han, Xuena
Fan, Zongmin
Wang, Ran
Li, Bei
Han, Wenli
Wang, Panpan
Li, Jilin
Wan, Lixin
Zhang, Liguo
Bao, Qide
Chang, Fubao
Qin, Yanru
Chang, Zhiwei
Ku, Jianwei
Yang, Haijun
Yuan, Ling
Ren, Jingli
Li, Xuemin
Wang, Lidong
author_facet Chen, Peinan
Zhao, Xueke
Zhou, Fuyou
Song, Xin
Hu, Shoujia
Jin, Yan
Wang, Xianzeng
Han, Xuena
Fan, Zongmin
Wang, Ran
Li, Bei
Han, Wenli
Wang, Panpan
Li, Jilin
Wan, Lixin
Zhang, Liguo
Bao, Qide
Chang, Fubao
Qin, Yanru
Chang, Zhiwei
Ku, Jianwei
Yang, Haijun
Yuan, Ling
Ren, Jingli
Li, Xuemin
Wang, Lidong
author_sort Chen, Peinan
collection PubMed
description Objective: There are no comprehensive studies on survival outcomes and optimal treatment protocols for cervical esophageal cancer (CEC), due to its rare clinical prevalence. Our objective was to determine the relationship between pathological characteristics, treatment protocols, and survival outcomes in Chinese CEC patients. Methods: A total of 500 Chinese CEC patients were selected from our 500,000 esophageal and gastric cardia carcinoma database (1973–2018). There were two main groups: patients treated with surgery, and patients receiving non-surgical treatments (radiotherapy, radiochemotherapy, and chemotherapy). The Chi-square test and Kaplan–Meier method were used to compare the continuous variables and survival. Results: Among the 500 CEC patients, 278 (55.6%) were male, and the median age was 60.9 ± 9.4 years. A total of 496 patients (99.2%) were diagnosed with squamous cell carcinoma. In 171 (34.2%) patients who received surgery, 22 (12.9%) had undergone laryngectomy. In 322 (64.4%) patients who received non-surgical treatments, 245 (76.1%) received radiotherapy. Stratified survival analysis showed that only T stage was related with survival outcomes for CEC patients in the surgical group, and the outcomes between laryngectomy and non-laryngectomy patients were similar. It was noteworthy that the 5-year survival rate was similar in CEC patients among the different groups treated with surgery, radiotherapy, chemotherapy, or radiochemotherapy (P = 0.244). Conclusions: The CEC patients had similar survival outcomes after curative esophagectomy and radiotherapy, including those with or without total laryngectomy. These findings suggest that radiotherapy could be the initial choice for treatment of Chinese CEC patients.
format Online
Article
Text
id pubmed-7142830
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Compuscript
record_format MEDLINE/PubMed
spelling pubmed-71428302020-04-15 Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes Chen, Peinan Zhao, Xueke Zhou, Fuyou Song, Xin Hu, Shoujia Jin, Yan Wang, Xianzeng Han, Xuena Fan, Zongmin Wang, Ran Li, Bei Han, Wenli Wang, Panpan Li, Jilin Wan, Lixin Zhang, Liguo Bao, Qide Chang, Fubao Qin, Yanru Chang, Zhiwei Ku, Jianwei Yang, Haijun Yuan, Ling Ren, Jingli Li, Xuemin Wang, Lidong Cancer Biol Med Original Article Objective: There are no comprehensive studies on survival outcomes and optimal treatment protocols for cervical esophageal cancer (CEC), due to its rare clinical prevalence. Our objective was to determine the relationship between pathological characteristics, treatment protocols, and survival outcomes in Chinese CEC patients. Methods: A total of 500 Chinese CEC patients were selected from our 500,000 esophageal and gastric cardia carcinoma database (1973–2018). There were two main groups: patients treated with surgery, and patients receiving non-surgical treatments (radiotherapy, radiochemotherapy, and chemotherapy). The Chi-square test and Kaplan–Meier method were used to compare the continuous variables and survival. Results: Among the 500 CEC patients, 278 (55.6%) were male, and the median age was 60.9 ± 9.4 years. A total of 496 patients (99.2%) were diagnosed with squamous cell carcinoma. In 171 (34.2%) patients who received surgery, 22 (12.9%) had undergone laryngectomy. In 322 (64.4%) patients who received non-surgical treatments, 245 (76.1%) received radiotherapy. Stratified survival analysis showed that only T stage was related with survival outcomes for CEC patients in the surgical group, and the outcomes between laryngectomy and non-laryngectomy patients were similar. It was noteworthy that the 5-year survival rate was similar in CEC patients among the different groups treated with surgery, radiotherapy, chemotherapy, or radiochemotherapy (P = 0.244). Conclusions: The CEC patients had similar survival outcomes after curative esophagectomy and radiotherapy, including those with or without total laryngectomy. These findings suggest that radiotherapy could be the initial choice for treatment of Chinese CEC patients. Compuscript 2020-02-15 2020-02-15 /pmc/articles/PMC7142830/ /pubmed/32296589 http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0268 Text en Copyright: © 2020, Cancer Biology & Medicine http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Chen, Peinan
Zhao, Xueke
Zhou, Fuyou
Song, Xin
Hu, Shoujia
Jin, Yan
Wang, Xianzeng
Han, Xuena
Fan, Zongmin
Wang, Ran
Li, Bei
Han, Wenli
Wang, Panpan
Li, Jilin
Wan, Lixin
Zhang, Liguo
Bao, Qide
Chang, Fubao
Qin, Yanru
Chang, Zhiwei
Ku, Jianwei
Yang, Haijun
Yuan, Ling
Ren, Jingli
Li, Xuemin
Wang, Lidong
Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes
title Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes
title_full Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes
title_fullStr Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes
title_full_unstemmed Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes
title_short Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes
title_sort characterization of 500 chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142830/
https://www.ncbi.nlm.nih.gov/pubmed/32296589
http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0268
work_keys_str_mv AT chenpeinan characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT zhaoxueke characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT zhoufuyou characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT songxin characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT hushoujia characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT jinyan characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT wangxianzeng characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT hanxuena characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT fanzongmin characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT wangran characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT libei characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT hanwenli characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT wangpanpan characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT lijilin characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT wanlixin characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT zhangliguo characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT baoqide characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT changfubao characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT qinyanru characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT changzhiwei characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT kujianwei characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT yanghaijun characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT yuanling characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT renjingli characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT lixuemin characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes
AT wanglidong characterizationof500chinesepatientswithcervicalesophagealcancerbyclinicopathologicalandtreatmentoutcomes